cannabisdeclaration.com/human-cases/

Autism Spectrum Disorder

Mutations found in individuals with autism interfere with endocannabinoid signaling in the brain (Science Daily)

Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders (PubMed)

A novel approach to the symptomatic treatment of autism (Lester Grinspoon M.D., O’Shaughnessy’s)

Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders (PubMed)

Targeting the endocannabinoid system in the treatment of fragile X syndrome (PubMed)

Autism Spectrum Disorders

Anxiety and Depression

Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug (PubMed)

Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis Sativa (PubMed)

Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients (PubMed)

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder (PubMed)

Plant-based medicines for anxiety disorders, part 2: A review of clinical studies with supporting preclinical evidence (PubMed)

ADHD

Association of the Cannabinoid Receptor Gene (CNR1) with ADHD and post-traumatic stress disorder PTSD, Lu et. al. (2008 Dec.)

Cannabis Improves Symptoms of ADHD, P. Strohbeck-Kuehner and al., Cannabinoids (2008 Mar.)

Subtypes of Attention Deficit — Hyperactivity Disorder (ADHD) and cannabis use (PubMed)

Searching for a Neurobiological Basis for Self-Medication Theory in ADHD Comorbid With Substance Use Disorders (Pub Med)

Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats (PubMed)

Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students (PubMed)

Oral delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: A case report (PubMed)

Alzheimer’s Disease

Prevention of Alzheimer’s Disease Pathology by Cannabinoids: Neuroprotection Mediated by Blockade of Microglial Activation (2005)

The therapeutic potential of the endocannabinoid system for Alzheimer’s disease.(2012)

Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer’s disease.

Activation of the CB2 receptor system reverses amyloid-induced memory deficiency

Marijuana’s Active Ingredient Shown to Inhibit Primary Marker of Alzheimer’s Disease

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic

Nonpsychotropic Cannabinoid Receptors RegulateMicroglial Cell Migration

Arthritis

Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis (PubMed)

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis (PubMed)

Involvement of the endocannabinoid system in osteoarthritis pain (PubMed)

 

Epilepsy

Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.

Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report.

Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.

https://www.higherperspectives.com/there-are-now-100-scientific-studies-that-prove-cannabis-cures-cancer-1429984852.html

cannabisdeclaration.com/supporting-evidence/

Sativa, Indica, and Hybrid: What’s the Difference Between Cannabis Types?  
https://www.leafly.com/news/cannabis-101/sativa-indica-and-hybrid-whats-the-difference-between-cannabis-ty

History of Medical Cannabis
https://en.wikipedia.org/wiki/History_of_medical_cannabis 
http://content.time.com/time/health/article/0,8599,1931247,00.html 
http://medicalmarijuana.procon.org/view.timeline.php?timelineID=000026